Skip to content
Back to glossary
Imaging & diagnostics

MR spectroscopy (MRS)

DEMR-Spektroskopie (MRS)

MR spectroscopy (MRS) measures the chemistry of your tissues non-invasively, on a standard MRI scanner. It reads the slight frequency shifts in the MR signal to quantify specific metabolites, usually from one small box (voxel) or a grid of them. In the brain, 1H-MRS measures things like NAA (a marker of healthy neurons), choline, creatine, lactate, myo-inositol, glutamate/glutamine, and glutathione. Those help with grading tumors, and studying mitochondrial disease, multiple sclerosis, and neurodegeneration. In the liver, a related technique (MR-PDFF) is the most accurate non-invasive measure of liver fat. It has become the imaging endpoint of choice in fatty-liver (MASLD/MASH) trials, matching biopsy grades well. MRS uses no radiation. Its limits: long scan times, sensitivity to motion and field unevenness, modest spatial detail, and the need for specialized processing.

Last reviewed:

This definition is educational and is not medical advice, a diagnosis, or treatment. Talk to a doctor about any health decisions. Read our full medical disclaimer

Sources

  1. Bottomley PA. (1988). Human in vivo phosphate metabolite imaging with 31P NMR. *Magnetic Resonance in Medicine*doi:10.1002/mrm.1910070309
  2. Caussy C, Reeder SB, Sirlin CB, Loomba R. (2018). Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials. *Hepatology*doi:10.1002/hep.29797
  3. Öz G, Alger JR, Barker PB, et al.. (2014). Clinical Proton MR Spectroscopy in Central Nervous System Disorders. *Radiology*doi:10.1148/radiol.13130531